Identifying health technologies that work : searching for evidence.DIANE Publishing, 1994 - 8 pages |
Other editions - View all
Common terms and phrases
activities administrative Agency for Health AHCPR American Medical Association analysis appropriate breast cancer Center clinical practice guidelines clinical trials clinicians comparative Consensus controlled trials cost-effectiveness cost-effectiveness analysis costs database decision decisionmaking Department of Health disease drug effectiveness research efforts evaluation evidence example federal guideline development guideline panels Health and Human Health Care Health Care Policy health outcomes health technology assessment hospital Human Services identify improve Institutes of Health interventions issues Journal of Medicine literature measures medical practice medical technologies Medicare ment meta-analysis methods myocardial infarction National Institute Office of Technology physicians Policy and Research PORTS Preventive Services procedures Program prostate providers Public Health Service publication bias RAND randomized randomized controlled trials rates RCTs recommendations relevant screening sponsored strategies studies surgery therapy tients tion tiveness topics treatment U.S. Congress U.S. Department urinary incontinence variation Washington
Popular passages
Page 289 - Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
Page 265 - ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.
Page 240 - Guidelines are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical conditions.
Page 241 - Groupings of diagnostic categories drawn from the International Classification of Diseases and modified by the presence of a surgical procedure, patient age, presence or absence of significant comorbidities or complications , and other relevant criteria.
Page 242 - Efficacy: The probability of benefit to individuals in a defined population from a medical technology applied for a given medical problem under ideal conditions of use.
Page 95 - HCFA, the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA) — are responsible for their own accounting.
Page 245 - quality of health care" as the evaluation of the performancee of health care providers according to the degree to which the process of care increases the probability of outcomes desired by patients and reduces the probability of undesired outcomes, given the state of medical knowledge.
Page 245 - Prospective payment: Payment for medical care on the basis of rates set in advance of the time period in which they apply. The unit of payment may vary from individual medical services to broader categories, such as hospital case, episode of illness, or person (capitation).
Page 245 - Health-related quality of life is the value assigned to duration of life as modified by the impairments, functional states, perceptions and social opportunities that are influenced by disease, injury, treatment, or policy